Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation.
Testicular germ cell tumours (TGCT) exhibit remarkable ability to differentiate into virtually all somatic tissue types. In this study, we investigated changes in mucin-type O-glycosylation, which have been associated with somatic cell differentiation and cancer. Expression profile of simple mucin-type O-glycans (Tn, sialyl-Tn, T), histo-blood group H and A variants and six polypeptide GalNAc-transferases (T1-4, T6, T11) that control the site and density of O-glycosylation were analysed by immunohistochemistry during human testis development and in TGCT. Normal testis showed a restricted pattern; gonocytes expressed abundant sialyl-Tn and sialyl-T, and adult spermatogonia were devoid of any glycans, whereas spermatocytes and spermatids expressed exclusively glycans Tn and T and the GalNAc-T3 isoform. A subset of mature ejaculated spermatozoa expressed an additional glycan sialyl-T. The pattern found in testicular neoplasms recapitulated the developmental order: Pre-invasive carcinoma in situ (CIS) cells and seminoma expressed fetal type sialylated glycans in keeping with their gonocyte-like phenotype. Neither simple mucin-type O-glycans nor GalNAc-transferase isoforms were found in undifferentiated nonseminoma, i.e. embryonal carcinoma, whereas teratomas expressed them all to some extent but in a disorganized manner. We concluded that simple mucin-type O-glycans and their transferases are developmentally regulated in the human testis, with profound changes associated with neoplasia. The restricted O-glycosylation pattern in haploid germ cells suggests a role in their maturation or egg recognition/fertilization warranting further studies in male infertility, whereas the findings in TGCT provide new diagnostic tools and support our hypothesis that testicular cancer is a developmental disease of germ cell differentiation.
Rajpert-De Meyts
E
E
University Department of Growth and Reproduction, Section GR-5064, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark. erm@rh.hosp.dk
Poll
S N
SN
Goukasian
I
I
Jeanneau
C
C
Herlihy
A S
AS
Bennett
E P
EP
Skakkebaek
N E
NE
Clausen
H
H
Giwercman
A
A
Mandel
U
U
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000235:genetics / Q000378:metabolism*; D000957:Antigens, Viral, Tumor / Q000235:genetics / Q000378:metabolism*; D002454:Cell Differentiation / Q000502:physiology; D002471:Cell Transformation, Neoplastic / Q000378:metabolism* / Q000473:pathology; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D017350:N-Acetylgalactosaminyltransferases / Q000235:genetics / Q000378:metabolism*; D010641:Phenotype; D013091:Spermatogenesis / Q000502:physiology; D013094:Spermatozoa / Q000473:pathology; D013736:Testicular Neoplasms / Q000378:metabolism* / Q000473:pathology; D013737:Testis / Q000378:metabolism* / Q000473:pathology; D000097763:Polypeptide N-acetylgalactosaminyltransferase
D015295:Antigens, Tumor-Associated, Carbohydrate; D000957:Antigens, Viral, Tumor; D017350:N-Acetylgalactosaminyltransferases; D000097763:Polypeptide N-acetylgalactosaminyltransferase; C040286:Tn antigen; C055491:sialosyl-Tn antigen
Hybridoma. 1984 Winter;3(4):347-61
6396197
Dev Biol. 1984 Jun;103(2):285-93
6144603
J Biol Chem. 1999 Sep 3;274(36):25362-70
10464263
Br J Cancer. 1996 Jul;74(1):133-40
8679447
Int J Cancer. 1996 Jun 11;66(6):806-16
8647654
Virchows Arch. 2006 Aug;449(2):200-6
16736189
J Biol Chem. 2002 Jun 21;277(25):22623-38
11925450
Cell. 2003 Aug 22;114(4):405-17
12941270
Virchows Arch. 1995;426(4):369-74
7599789
J Clin Endocrinol Metab. 2005 Apr;90(4):2420-3
15687324
J Biol Chem. 1998 Nov 13;273(46):30472-81
9804815
Nat Genet. 2004 Jun;36(6):579-81
15133511
Lab Invest. 1995 Feb;72(2):223-31
7531795
J Biol Chem. 2005 Jul 22;280(29):27310-8
15917254
Nat Rev Cancer. 2005 Jul;5(7):526-42
16069816
APMIS. 2003 Jan;111(1):267-78; discussion 278-9
12752272
Lancet. 1972 Sep 9;2(7776):516-7
4115573
Glycobiology. 1996 Sep;6(6):635-46
8922959
Int J Androl. 1987 Feb;10(1):19-28
3034791
Glycoconj J. 2001 Nov-Dec;18(11-12):883-93
12820722
Glycobiology. 1998 Jun;8(6):547-55
9592121
Cancer Res. 2003 May 1;63(9):2244-50
12727846
J Clin Pathol. 2006 Apr;59(4):440-2
16567474
APMIS. 1991 May;99(5):391-7
1710473
J Biol Chem. 1995 Nov 3;270(44):26025-8
7592795
APMIS. 1998 Jan;106(1):198-204; discussion 204-6
9524579
Proc Natl Acad Sci U S A. 1986 Jul;83(14):5291-5
3523489
Hum Reprod Update. 1999 Jul-Aug;5(4):314-29
10465523
Am J Dermatopathol. 2005 Jun;27(3):211-5
15900124
Glycobiology. 1999 Jan;9(1):43-52
9884405
Nat Rev Drug Discov. 2005 Jun;4(6):477-88
15931257
EMBO Rep. 2006 Jun;7(6):599-604
16741504
Hum Reprod Update. 2006 May-Jun;12(3):303-23
16540528
Int J Cancer. 1994 Jul 1;58(1):108-15
8014006
J Invest Dermatol. 1991 Oct;97(4):713-21
1940443
Histopathology. 2005 Jul;47(1):48-56
15982323
Acta Pathol Microbiol Immunol Scand A. 1984 Sep;92(5):323-9
6209917
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6193-7
9600940
Cancer Res. 2004 Jul 15;64(14):4736-43
15256440
Hum Reprod. 2002 Aug;17(8):2199-208
12151459
Science. 1984 Jun 15;224(4654):1198-206
6729450
Am J Pathol. 2005 Mar;166(3):913-21
15743802
Cancer. 2005 Nov 15;104(10 ):2092-8
16206293
J Biol Chem. 2004 Sep 10;279(37):38838-43
15231832